- 2025-05-20 09:41GNE-781 1936422-33-1
- 2025-05-20 09:41Triciferol 957214-00-5
- 2025-05-20 09:41GNE-272 1936428-93-1
- 2025-05-20 09:40TNG260 2935964-98-8
- 2025-05-20 09:40Gal-ARV-771
- 2025-05-20 09:40Suprastat 90093-40-6
- 2025-05-20 09:40FL-411 2118944-88-8
- 2025-05-20 09:40SS-208 2245942-72-5
- 2025-05-20 09:40FHT-2344 2468058-90-2
- 2025-05-20 09:40SR-4370 1816294-67-3
- 2025-05-20 09:40FHD-609 2676211-64-4
- 2025-05-20 09:40SP-2-225 2364448-93-9
- 2025-05-20 09:40EP300/CBP-IN-2 2379527-49-6
- 2025-05-20 09:40SHP2/HDAC-IN-1 2831230-38-5
- 2025-05-20 09:40EP300/CBP-IN-1 2638507-71-6
- 2025-05-20 09:40PB131 2924425-63-6
- 2025-05-20 09:40EP300/CBP ligand 2
- 2025-05-20 09:40NT160 1418293-40-9
- 2025-05-20 09:40Emilumenib (Menin-MLL inhibitor 26) 2440018-29-9
- 2025-05-20 09:40NR160 2484895-50-1
